Clinical Trial

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

Name: Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma — clinical trial record (NCT07588698)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggressive B-cell non-Hodgkin lymphoma.

Trial Details

NCT Number	NCT07588698
Lead Sponsor	Mwanasha Merrill, MD
Conditions	Non-Hodgkin's B-cell Lymphoma, Lymphoma Non-Hodgkin, Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment	20 participants
Start Date	2026-07-15
Primary Completion	2028-07-31 (estimated)
Study Completion	2029-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-15